Login / Signup

Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy.

Pere DomingoMaría Gracia MateoJoan VillarroyaRubén CereijoFerràn TorresJoan Carles DomingoLaura CampderrósJosé M Gallego-EscuredoMaría Del Mar GutierrezIsabel MurNoemí CorbachoFrancesc VidalFrancesc VillarroyaMarta Giralt
Published in: Journal of clinical medicine (2022)
PLWH, especially when cART-treated, has increased GDF15 levels-this increase is associated with dyslipidemia, insulin resistance, metabolic syndrome, HALS, and inflammation-related parameters. GDF15 is unassociated with CVR when age-adjusted.
Keyphrases